PIA
ATRC icon

Piedmont Investment Advisors’s AtriCure ATRC Stock Holding History

Piedmont Investment Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-582
Closed -$16K – 1134
2018
Q2 		$16K Buy
+582
New +$13.7K ﹤0.01% 1649

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Piedmont Investment Advisors's ATRC Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of AtriCure (ATRC) in Q3 2018, closing a stake of 582 shares — an estimated $16K sold.

Piedmont Investment Advisors first reported a position in ATRC in Q2 2018 and held it in 1 quarter. The position peaked at $16K in Q2 2018. 126 funds tracked by Wall St. Rank hold ATRC as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining AtriCure position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 582 AtriCure shares in Q3 2018, an estimated $16K.
  • Piedmont Investment Advisors first reported a position in AtriCure in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's AtriCure position peaked at $16K in Q2 2018.
  • 126 funds tracked by Wall St. Rank held AtriCure as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.